Skip to main content

Table 2 LEA gene in upland cotton, Gossypium hirsutum and their sequence characteristics and subcellular location prediction and chromosome position

From: Characterization of the late embryogenesis abundant (LEA) proteins family and their role in drought stress tolerance in upland cotton

GENE ID PROTEIN TYPE GENE ANNOTATION LENGTH (aa) Pl MM(aa) Chr NO Start End Position Sub cellular localization
Wolfpsort Pprowler TargetP
CotAD_ 04417 DEHYDRIN DEHYDRIN-4 98 6.33 10,753.6 At_chr08 2,270,863 2,271,159 296 nucl other _
CotAD_ 07367 DEHYDRIN DEHYDRIN-24 1431 6.31 160,755.92 scaffold72.1 2,201,874 2,209,455 7581 plas other _
CotAD_ 08352 DEHYDRIN DEHYDRIN-23 160 5.45 17,797.83 scaffold190.1 910,057 911,647 1590 nucl other _
CotAD_ 10,502 DEHYDRIN DEHYDRIN-8 235 8.18 26,216.65 Dt01_chr15 2,276,230 2,277,176 946 nucl other _
CotAD_ 11,398 DEHYDRIN DEHYDRIN-13 51 6.52 5513.09 Dt06_chr25 776,882 777,140 258 nucl other S
CotAD_ 13,947 DEHYDRIN DEHYDRIN-19 449 4.92 49,643.3 Dt13_chr18 1,193,127 1,196,473 3346 nucl other _
CotAD_ 15,928 DEHYDRIN DEHYDRIN-18 180 7.98 19,341.26 Dt12_chr26 638,305 639,445 1140 nucl other _
CotAD_ 16,331 DEHYDRIN DEHYDRIN-15 128 5.46 14,436.09 Dt08_chr24 877,320 877,836 516 mito other _
CotAD_ 19,173 DEHYDRIN DEHYDRIN-5 180 7.98 19,330.23 At_chr12 883,350 884,512 1162 cyto other _
CotAD_ 22,357 DEHYDRIN DEHYDRIN-2 197 5.48 22,224.51 At_chr02 824,855 825,544 689 chlo other _
CotAD_ 27,143 DEHYDRIN DEHYDRIN-14 135 9.49 14,720.04 Dt07_chr16 115,939 116,435 496 chlo other _
CotAD_ 29,610 DEHYDRIN DEHYDRIN-16 172 5.89 19,224.36 Dt08_chr24 936,161 936,813 652 cyto other _
CotAD_ 31,255 DEHYDRIN DEHYDRIN-10 199 5.5 22,423.72 Dt02_chr14 711,572 712,266 694 chlo other _
CotAD_ 35,513 DEHYDRIN DEHYDRIN-12 161 4.79 17,827.6 Dt05_chr19 393,056 394,685 1629 chlo other _
CotAD_ 42,408 DEHYDRIN DEHYDRIN-20 344 9.01 37,987.42 Dt13_ch18 453,295 454,329 1034 chlo other _
CotAD_ 46,550 DEHYDRIN DEHYDRIN-1 135 9.33 14,717.04 At_chr01 69,396 69,892 496 cyto other _
CotAD_ 50,983 DEHYDRIN DEHYDRIN-9 243 8.82 26,199.73 Dt02_chr14 297,459 298,432 973 cyto other _
CotAD_ 53,264 DEHYDRIN DEHYDRIN-22 211 5.04 23,789.31 scaffold1899.1 95,851 96,576 725 cyto other _
CotAD_ 57,587 DEHYDRIN DEHYDRIN-17 211 5.22 23,654.28 Dt09_chr23 187,778 188,503 725 cyto other _
CotAD_ 64,203 DEHYDRIN DEHYDRIN-6 178 6.48 19,521.14 At_chr13 125,424 126,358 934 chlo other _
CotAD_ 65,889 DEHYDRIN DEHYDRIN-11 608 5.62 67,130.02 Dt03_chr17 396,530 401,988 5458 cyto other _
CotAD_ 70,948 DEHYDRIN DEHYDRIN-21 332 8.46 37,102.53 Dt13_chr18 41,714 42,880 1166 chlo other _
CotAD_ 75,267 DEHYDRIN DEHYDRIN-7 332 8.22 37,096.42 At_chr13 210,365 211,531 1166 nucl other _
CotAD_ 75,537 DEHYDRIN DEHYDRIN-3 533 5.39 58,793.08 At_chr03 254,566 259,519 4953 plas other _
CotAD_ 16,594 LEA1 LEA 1–7 115 6.9 13,315.99 Dt13_chr18 1,203,659 1,204,098 439 mito other _
CotAD_ 16,595 LEA1 LEA 1–8 115 6.9 13,315.99 Dt13_chr18 1,204,716 1,205,155 439 cyto other _
CotAD_ 17,186 LEA1 LEA 1–1 165 5.81 17,459.58 At_chr06 1,273,709 1,274,303 594 plas other _
CotAD_ 20,491 LEA1 LEA 1–6 165 6.08 17,343.5 Dt06_chr25 298,147 298,732 585 cyto other _
CotAD_ 30,219 LEA1 LEA 1–2 113 6.3 12,106.42 Dt02_chr14 23,536 24,035 499 chlo other _
CotAD_ 31,140 LEA1 LEA 1–3 164 9.3 16,871.44 Dt02_chr14 28,053 28,616 563 cyto other _
CotAD_ 48,976 LEA1 LEA 1–9 116 8.01 13,437.07 scaffold842.1 284,300 284,742 442 chlo other _
CotAD_ 51,667 LEA1 LEA 1–4 164 9.33 16,897.52 Dt02_chr14 443,597 444,162 565 nucl other _
CotAD_ 52,203 LEA1 LEA 1–5 420 9.1 45,990.36 Dt02_chr14 444,540 450,345 5805 cyto other _
CotAD_ 00275 LEA2 LEA 2–98 274 10.09 29,834.66 Dt09_chr23 2,049,164 2,049,988 824 chlo other M
CotAD_ 00465 LEA2 LEA 2–101 304 9.59 33,689.28 Dt09_chr23 3,367,709 3,368,936 1227 chlo other M
CotAD_ 00799 LEA2 LEA 2–154 337 8.96 38,982.02 scaffold26.1 2,048,605 2,051,804 3199 golg other M
CotAD_ 00808 LEA2 LEA 2–155 226 10.08 26,011.22 scaffold26.1 2,100,130 2,100,810 680 cyto other M
CotAD_ 01033 LEA2 LEA 2–105 202 9.06 22,587.14 Dt10_chr20 1,010,984 1,011,592 608 chlo other M
CotAD_ 01298 LEA2 LEA 2–107 218 10.22 24,021.4 Dt10_chr20 5,288,414 5,289,070 656 cyto other _
CotAD_ 01321 LEA2 LEA 2–108 238 9.54 26,020.28 Dt10_chr20 5,756,514 5,757,230 716 cyto SP M
CotAD_ 01385 LEA2 LEA 2–89 247 7 27,497.03 Dt09_chr23 159,994 161,690 1696 cyto other _
CotAD_ 01700 LEA2 LEA 2–100 260 9.36 28,399.83 Dt09_chr23 2,815,779 2,816,561 782 cyto other _
CotAD_ 02652 LEA2 LEA 2–97 212 10.05 23,764.43 Dt09_chr23 2,032,508 2,033,146 638 mito other _
CotAD_ 03037 LEA2 LEA 2–63 262 9.05 28,472.57 Dt05_chr19 1,838,069 1,841,145 3076 cyto other _
CotAD_ 03649 LEA2 LEA 2–34 320 9.82 35,345.6 At_chr09 1,775,719 1,776,844 1125 cyto other _
CotAD_ 03784 LEA2 LEA 2–75 116 6.82 13,537.66 Dt07_chr16 548,573 548,923 350 chlo other _
CotAD_ 05724 LEA2 LEA 2–32 197 10.05 22,442.51 At_chr09 1,755,547 1,756,140 593 chlo other/SP _
CotAD_ 05725 LEA2 LEA 2–33 238 9.73 27,552.78 At_chr09 1,759,512 1,760,228 716 nucl SP _
CotAD_ 06037 LEA2 LEA 2–115 205 10.07 22,125.81 Dt13_ch18 90,455 91,072 617 chlo SP _
CotAD_ 07087 LEA2 LEA2–3 206 9.75 22,853.64 At_chr02 2,101,730 2,102,350 620 plas other _
CotAD_ 08181 LEA2 LEA 2–99 202 8.61 22,460.02 Dt09_chr23 2,228,567 2,229,175 608 cyto SP _
CotAD_ 08350 LEA2 LEA 2–152 198 5.02 22,266.98 scaffold190.1 904,483 905,252 769 chlo SP _
CotAD_ 08837 LEA2 LEA 2–125 245 8.77 26,376.34 scaffold280.1 51,952 53,959 2007 golg other _
CotAD_ 09578 LEA2 LEA 2–30 260 9.39 28,406.84 At_chr09 1,173,118 1,173,900 782 chlo other _
CotAD_ 09685 LEA2 LEA 2–93 251 10.07 27,153.8 Dt09_chr23 686,730 687,485 755 chlo SP C
CotAD_ 09732 LEA2 LEA 2–96 232 9.44 25,906.5 Dt09_chr23 1,174,994 1,175,943 949 chlo other _
CotAD_ 10,376 LEA2 LEA 2–48 277 9.92 30,152.74 Dt01_chr15 100,033 100,866 833 chlo SP M
CotAD_ 11,658 LEA2 LEA 2–84 263 9.82 29,835.19 Dt08_chr24 199,067 199,858 791 cyto SP M
CotAD_ 11,875 LEA2 LEA 2–147 175 6.95 20,070.28 scaffold42.1 647,003 647,530 527 chlo SP M
CotAD_ 11,876 LEA2 LEA 2–148 209 10.01 23,563.32 scaffold42.1 677,153 677,782 629 chlo SP _
CotAD_ 11,878 LEA2 LEA 2–149 226 9.49 25,841.73 scaffold42.1 688,643 689,323 680 chlo SP _
CotAD_ 11,879 LEA2 LEA 2–150 129 9.45 15,037.05 scaffold42.1 690,007 690,396 389 chlo SP _
CotAD_ 12,375 LEA2 LEA 2–25 190 8.59 21,328.78 At_chr09 106,696 107,358 662 chlo SP _
CotAD_ 13,115 LEA2 LEA 2–86 192 9.42 20,770.35 Dt08_chr24 1,183,052 1,183,630 578 extr SP _
CotAD_ 13,584 LEA2 LEA 2–67 250 9.96 28,048.83 Dt06_chr25 364,402 365,154 752 golg SP _
CotAD_ 13,827 LEA2 LEA 2–114 360 7.87 40,945.87 Dt12_chr26 971,427 972,748 1321 E.R. mTP C
CotAD_ 14,147 LEA2 LEA 2–16 212 9.94 23,855.54 At_chr07 774,151 774,789 638 mito SP S
CotAD_ 15,892 LEA2 LEA 2–112 307 7.7 34,741.21 Dt12_chr26 406,661 409,153 2492 chlo mTP _
CotAD_ 16,731 LEA2 LEA 2–94 258 10.01 28,519.44 Dt09_chr23 724,944 725,720 776 chlo other _
CotAD_ 17,044 LEA2 LEA 2–17 151 4.84 16,422.87 At_chr07 972,098 972,634 536 cyto SP S
CotAD_ 17,045 LEA2 LEA 2–18 219 9.79 23,930.18 At_chr07 992,750 993,409 659 cyto SP _
CotAD_ 17,062 LEA2 LEA 2–19 244 9.78 27,393.16 At_chr07 1,176,161 1,176,895 734 chlo mTP C
CotAD_ 17,101 LEA2 LEA 2–9 222 9.26 25,294.09 At_chr06 94,601 95,269 668 mito SP S
CotAD_ 17,102 LEA2 LEA 2–10 209 10.35 23,661.48 At_chr06 122,145 122,774 629 nucl SP _
CotAD_ 17,103 LEA2 LEA 2–11 265 6.7 30,299.29 At_chr06 134,827 135,702 875 mito SP C
CotAD_ 17,649 LEA2 LEA 2–37 235 8.5 26,726.9 At_chr10 359,189 361,440 2251 chlo SP _
CotAD_ 18,210 LEA2 LEA 2–141 203 10.17 22,501.33 scaffold377.1 414,366 414,977 611 cyto SP C
CotAD_ 18,233 LEA2 LEA 2–145 203 10.08 22,406.26 scaffold377.1 560,351 560,962 611 chlo SP _
CotAD_ 18,546 LEA2 LEA 2–95 173 9.91 19,695.85 Dt09_chr23 893,109 893,715 606 chlo mTP M
CotAD_ 18,729 LEA2 LEA 2–142 277 9.92 30,227.97 scaffold336.1 433,013 433,846 833 chlo SP _
CotAD_ 19,078 LEA2 LEA 2–42 216 9.83 24,007.7 At_chr12 18,103 18,753 650 nucl other _
CotAD_ 19,107 LEA2 LEA 2–43 183 9.04 20,031.24 At_chr12 312,977 313,528 551 chlo SP C
CotAD_ 19,205 LEA2 LEA 2–46 297 6.83 33,395.7 At_chr12 1,142,954 1,145,475 2521 chlo SP S
CotAD_ 19,213 LEA2 LEA 2–38 100 9.64 11,538.35 At_chr10 410,401 410,703 302 chlo mTP _
CotAD_ 19,214 LEA2 LEA 2–39 181 9.32 20,628.72 At_chr10 411,491 412,036 545 nucl SP S
CotAD_ 19,375 LEA2 LEA 2–111 225 8.57 25,956.2 Dt11_chr21 1,023,165 1,023,842 677 golg mTP C
CotAD_ 20,020 LEA2 LEA 2–13 250 9.89 27,947.68 At_chr06 997,148 997,900 752 mito SP _
CotAD_ 20,308 LEA2 LEA 2–72 191 9.56 21,054.44 Dt06_chr25 1,390,037 1,390,612 575 chlo cTP C
CotAD_ 21,731 LEA2 LEA 2–62 244 9.83 27,381.21 Dt05_chr19 1,524,633 1,525,367 734 nucl other _
CotAD_ 21,924 LEA2 LEA 2–110 262 10.16 28,411.4 Dt11_chr21 855,130 855,918 788 nucl SP S
CotAD_ 23,646 LEA2 LEA 2–74 204 9.81 21,921.93 Dt07_chr16 34,227 34,841 614 nucl SP _
CotAD_ 24,019 LEA2 LEA 2–71 203 10.04 22,391.06 Dt06_chr25 652,496 653,107 611 mito SP S
CotAD_ 24,497 LEA2 LEA 2–106 263 8.64 29,247.79 Dt10_chr20 1,715,959 1,719,093 3134 chlo other _
CotAD_ 24,499 LEA2 LEA 2–138 175 7.66 20,026.25 scaffold238.1 343,833 344,360 527 chlo SP _
CotAD_ 25,271 LEA2 LEA 2–139 209 10.01 23,559.33 scaffold238.1 356,524 357,153 629 nucl SP _
CotAD_ 26,038 LEA2 LEA 2–140 226 9.43 25,852.71 scaffold238.1 383,318 383,998 680 chlo SP S
CotAD_ 26,981 LEA2 LEA 2–26 274 10.09 29,936.66 At_chr09 239,371 240,195 824 chlo other _
CotAD_ 27,453 LEA2 LEA 2–131 239 9.76 26,994.13 scaffold477.1 176,874 179,526 2652 mito SP _
CotAD_ 27,789 LEA2 LEA 2–151 184 9.41 20,135.39 scaffold699.1 759,396 759,950 554 E.R. SP M
CotAD_ 28,249 LEA2 LEA 2–27 150 9.24 16,764.6 At_chr09 274,309 275,011 702 nucl SP _
CotAD_ 28,252 LEA2 LEA 2–13 222 8.65 24,982.77 At_chr07 296,696 299,063 2367 mito other _
CotAD_ 28,872 LEA2 LEA 2–57 257 9.1 26,949.97 Dt03_chr17 1,936,828 1,937,663 835 nucl SP _
CotAD_ 29,279 LEA2 LEA 2–116 305 9.66 34,588.47 Dt13_chr18 639,522 641,549 2027 chlo SP _
CotAD_ 31,344 LEA2 LEA 2–132 101 5.51 11,711.01 scaffold1346.1 193,028 193,333 305 chlo other _
CotAD_ 31,535 LEA2 LEA 2–8 240 7.89 27,649.86 At_chr05 790,866 791,588 722 vacu other _
CotAD_ 31,536 LEA2 LEA 2–136 210 9.19 23,875.63 scaffold1346.1 213,521 214,153 632 plas SP _
CotAD_ 31,537 LEA2 LEA 2–133 254 10.22 27,558.52 scaffold1841.1 200,526 201,290 764 nucl cTP C
CotAD_ 31,780 LEA2 LEA 2–87 310 9.93 34,525.38 Dt08_chr24 1,487,296 1,488,516 1220 chlo other _
CotAD_ 31,782 LEA2 LEA 2–90 210 7.72 23,638.39 Dt09_chr23 194,606 195,238 632 chlo SP _
CotAD_ 31,860 LEA2 LEA 2–153 206 9.82 22,839.69 scaffold257.1 1,162,406 1,163,026 620 cyto SP _
CotAD_ 31,906 LEA2 LEA 2–137 232 9.66 26,256.38 scaffold769.1 292,760 295,431 2671 cyto mTP M
CotAD_ 31,936 LEA2 LEA 2–53 152 4.74 16,462.97 Dt01_chr15 598,039 598,839 800 mito SP _
CotAD_ 32,487 LEA2 LEA 2–36 305 9.97 33,718.76 At_chr11 169,902 171,217 1315 mito other _
CotAD_ 32,645 LEA2 LEA 2–66 199 9.3 22,785.41 Dt06_chr25 246,850 247,449 599 chlo SP C
CotAD_ 32,847 LEA2 LEA 2–24 249 9.79 27,707.74 At_chr09 61,155 61,904 749 extr cTP C
CotAD_ 33,143 LEA2 LEA 2–54 305 9.63 34,544.43 Dt02_chr14 1,894,174 1,896,197 2023 chlo SP _
CotAD_ 33,144 LEA2 LEA 2–60 240 8.49 27,655.92 Dt05_chr19 151,373 152,095 722 chlo SP S
CotAD_ 34,476 LEA2 LEA 2–92 320 9.92 35,579.84 Dt09_chr23 448,827 449,952 1125 cyto SP _
CotAD_ 34,798 LEA2 LEA 2–68 222 9.23 25,253.03 Dt06_chr25 385,794 386,462 668 nucl SP _
CotAD_ 35,069 LEA2 LEA 2–69 209 10.25 23,628.4 Dt06_chr25 396,513 397,142 629 chlo SP _
CotAD_ 35,091 LEA2 LEA 2–70 288 7.1 32,755.52 Dt06_chr25 403,729 404,595 866 extr SP _
CotAD_ 35,514 LEA2 LEA 2–61 206 5.9 23,420.27 Dt05_chr19 399,904 400,524 620 mito SP C
CotAD_ 36,328 LEA2 LEA 2–144 450 4.92 49,131.5 scaffold821.1 548,888 550,240 1352 chlo other _
CotAD_ 36,446 LEA2 LEA 2–78 231 9.47 24,949.39 Dt08_chr24 58,782 59,477 695 chlo other _
CotAD_ 36,583 LEA2 LEA 2–146 206 8.88 22,761.2 scaffold821.1 625,818 626,438 620 chlo other _
CotAD_ 37,776 LEA2 LEA 2–91 202 9.02 22,357.93 Dt09_chr23 337,931 338,539 608 chlo SP S
CotAD_ 37,888 LEA2 LEA 2–21 283 10.15 31,410.18 At_chr08 2,313,418 2,314,578 1160 chlo other _
CotAD_ 38,978 LEA2 LEA 2–85 210 9.76 22,644.27 Dt08_chr24 376,609 377,241 632 nucl SP S
CotAD_ 39,064 LEA2 LEA 2–50 210 9.48 23,699.74 Dt01_chr15 220,837 221,469 632 chlo other _
CotAD_ 39,719 LEA2 LEA 2–52 191 6.29 20,961.07 Dt01_chr15 397,156 397,731 575 nucl mTP _
CotAD_ 40,324 LEA2 LEA 2–15 204 9.81 21,780.76 At_chr07 720,430 721,044 614 plas SP _
CotAD_ 41,569 LEA2 LEA 2–47 208 10.19 22,559.45 At_chr13 343,514 344,140 626 chlo other _
CotAD_ 41,571 LEA2 LEA 2–88 270 9.56 30,627.54 Dt09_chr23 64,512 65,324 812 chlo SP _
CotAD_ 41,925 LEA2 LEA 2–128 188 9.22 21,941.4 scaffold1231.1 94,270 94,836 566 nucl other _
CotAD_ 42,599 LEA2 LEA 2–129 373 9.9 43,118.75 scaffold1231.1 96,297 98,517 2220 cyto Other M
CotAD_ 44,357 LEA2 LEA 2–143 210 9.34 23,874.6 scaffold1088.1 451,853 452,485 632 cyto other C
CotAD_ 45,324 LEA2 LEA 2–109 256 9.99 28,431.93 Dt11_chr21 55,317 61,829 6512 chlo other _
CotAD_ 46,873 LEA2 LEA 2–29 259 10 28,603.52 At_chr09 355,476 356,255 779 vacu other _
CotAD_ 47,322 LEA2 LEA2–5 220 9.85 24,666.72 At_chr03 430,461 431,123 662 chlo SP _
CotAD_ 47,454 LEA2 LEA 2–130 661 6.14 73,583.12 scaffold1851.1 116,914 132,924 16,010 cysk SP C
CotAD_ 47,495 LEA2 LEA 2–76 318 10.09 35,234.15 Dt07_chr16 1,185,327 1,186,479 1152 chlo SP S
CotAD_ 47,749 LEA2 LEA 2–77 251 9.41 27,769.63 Dt07_chr16 1,400,323 1,401,078 755 chlo mTP M
CotAD_ 48,050 LEA2 LEA 2–103 217 9.28 24,968.87 Dt10_chr20 968,935 969,588 653 mito other _
CotAD_ 48,069 LEA2 LEA 2–104 181 9.57 20,577.73 Dt10_chr20 970,347 970,892 545 extr SP S
CotAD_ 48,336 LEA2 LEA 2–58 211 9.12 23,479.93 Dt04_chr22 552,418 553,053 635 nucl SP _
CotAD_ 48,753 LEA2 LEA 2–12 210 9.28 23,676.69 At_chr06 482,445 483,077 632 mito SP _
CotAD_ 48,769 LEA2 LEA 2–28 304 9.56 33,675.21 At_chr09 334,020 335,245 1225 nucl SP _
CotAD_ 49,818 LEA2 LEA 2–119 317 4.63 35,274.16 scaffold2616.1 21,219 22,172 953 cyto SP _
CotAD_ 53,045 LEA2 LEA 2–102 206 7.58 22,650.27 Dt10_chr20 363,682 364,302 620 cyto cTP C
CotAD_ 53,263 LEA2 LEA 2–23 251 10.11 27,168.81 At_chr09 24,397 25,152 755 chlo SP _
CotAD_ 53,981 LEA2 LEA 2–123 247 6.59 27,715.29 scaffold3326.1 42,209 43,944 1735 mito cTP C
CotAD_ 54,337 LEA2 LEA 2–14 152 4.84 16,453.02 At_chr07 366,521 367,321 800 chlo SP S
CotAD_ 55,224 LEA2 LEA 2–55 210 9.66 23,769.83 Dt03_chr17 607,531 608,163 632 mito SP M
CotAD_ 56,356 LEA2 LEA 2–22 173 9.96 19,737.98 At_chr09 18,712 19,318 606 chlo SP S
CotAD_ 56,696 LEA2 LEA 2–56 213 9.51 23,750.48 Dt03_chr17 634,717 635,358 641 nucl SP _
CotAD_ 58,358 LEA2 LEA 2–113 209 10.19 23,626.51 Dt12_ch26 897,133 897,762 629 chlo SP S
CotAD_ 59,405 LEA2 LEA 2–61 320 9.9 35,457.72 Dt05_chr19 251,378 252,501 1123 chlo SP S
CotAD_ 60,279 LEA2 LEA 2–124 247 8.76 26,619.63 scaffold2414.1 50,037 52,048 2011 chlo SP _
CotAD_ 60,435 LEA2 LEA2–1 251 9.57 27,952.81 At_chr01 137,428 138,183 755 chlo cTP C
CotAD_ 60,617 LEA2 LEA 2–49 210 9.51 23,780.9 Dt01_chr15 198,189 198,821 632 mito SP _
CotAD_ 61,173 LEA2 LEA2–7 215 9.84 24,043 At_chr04 59,864 60,511 647 chlo cTP _
CotAD_ 61,391 LEA2 LEA 2–51 191 6.29 20,884.97 Dt01_chr15 284,374 284,949 575 chlo SP C
CotAD_ 62,996 LEA2 LEA2–2 318 9.95 35,356.25 At_chr01 176,895 178,045 1150 nucl SP _
CotAD_ 63,174 LEA2 LEA 2–117 377 9.77 41,228.93 scaffold3177.1 19,137 21,221 2084 E.R. SP C
CotAD_ 64,004 LEA2 LEA 2–73 219 9.65 23,825.02 Dt07_chr16 34,198 34,857 659 chlo other _
CotAD_ 64,120 LEA2 LEA 2–41 218 10.14 24,050.43 At_chr12 951 1607 656 chlo SP _
CotAD_ 64,346 LEA2 LEA 2–64 210 8.99 23,572.5 Dt06_chr25 59,643 60,275 632 chlo SP _
CotAD_ 64,347 LEA2 LEA 2–65 235 9.44 26,111.93 Dt06_chr25 62,524 63,231 707 plas cTP C
CotAD_ 64,657 LEA2 LEA 2–40 262 10.22 28,516.58 At_chr11 144,295 145,083 788 vacu SP _
CotAD_ 65,119 LEA2 LEA 2–79 206 8.88 22,733.19 Dt08_chr24 59,660 60,280 620 golg SP _
CotAD_ 65,370 LEA2 LEA 2–126 326 9.99 36,098.18 scaffold3528.1 84,696 86,784 2088 chlo other _
CotAD_ 66,245 LEA2 LEA 2–82 450 4.94 48,836.2 Dt08_chr24 121,249 122,601 1352 chlo other _
CotAD_ 66,538 LEA2 LEA2–6 211 9.47 23,424.96 At_chr04 59,282 59,917 635 chlo SP _
CotAD_ 66,551 LEA2 LEA 2–118 225 9.28 25,226.24 scaffold3976.1 20,354 21,031 677 cyto other _
CotAD_ 66,774 LEA2 LEA 2–80 216 9.92 24,090.84 Dt08_chr24 68,424 69,074 650 chlo SP _
CotAD_ 66,775 LEA2 LEA 2–81 225 9.61 25,078.29 Dt08_chr24 72,945 73,622 677 chlo SP S
CotAD_ 67,823 LEA2 LEA 2–20 222 9.49 23,928.26 At_chr08 132,953 133,621 668 cyto SP S
CotAD_ 68,063 LEA2 LEA2–4 218 9.3 23,245.72 At_chr03 191,498 192,154 656 cyto SP _
CotAD_ 68,189 LEA2 LEA 2–35 206 6.71 22,579.21 At_chr10 67,607 68,227 620 chlo cTP C
CotAD_ 69,737 LEA2 LEA 2–134 213 9.75 23,867.69 scaffold2095.1 202,243 202,884 641 chlo SP S
CotAD_ 69,738 LEA2 LEA 2–135 210 9.88 23,893.04 scaffold2095.1 208,893 209,525 632 chlo SP _
CotAD_ 70,003 LEA2 LEA 2–42 191 9.63 20,942.44 At_chr12 171,793 172,368 575 cyto cTP C
CotAD_ 70,190 LEA2 LEA 2–120 430 4.81 48,185.02 scaffold4817.1 31,921 37,140 5219 cyto other _
CotAD_ 70,192 LEA2 LEA 2–122 130 4.74 14,420.49 scaffold4817.1 38,397 38,789 392 nucl SP M
CotAD_ 71,431 LEA2 LEA 2–59 186 9.58 20,579.98 Dt05_chr19 65,530 66,090 560 extr other _
CotAD_ 72,458 LEA2 LEA 2–127 192 9.54 20,613.31 scaffold3083.1 91,828 92,406 578 cysk SP _
CotAD_ 72,913 LEA2 LEA 2–121 315 4.63 35,071.89 scaffold4398.1 34,689 36,390 1701 cysk SP _
CotAD_ 73,966 LEA2 LEA 2–45 320 9.96 35,484.73 At_chr12 365,460 366,583 1123 chlo other _
CotAD_ 74,713 LEA2 LEA 2–83 211 9.12 23,479.93 Dt08_chr24 158,342 158,977 635 golg other _
CotAD_ 76,129 LEA2 LEA 2–44 209 10.19 23,626.51 At_chr12 317,009 317,638 629 chlo other _
CotAD_ 01504 LEA3 LEA 3–13 93 8.82 10,469.06 Dt09_chr23 1,171,108 1,171,516 408 chlo other C
CotAD_ 04558 LEA3 LEA 3–1 100 9.75 10,627.15 At_chr04 288,394 288,796 402 chlo mTP S
CotAD_ 04559 LEA3 LEA 3–2 100 9.34 10,419.9 At_chr04 291,007 291,400 393 chlo SP S
CotAD_ 21,416 LEA3 LEA 3–9 92 9.83 9667.02 Dt04_chr22 127,037 127,390 353 chlo mTP C
CotAD_ 22,634 LEA3 LEA 3–11 100 9.18 10,503.02 Dt04_chr22 853,079 853,496 417 mito SP S
CotAD_ 23,118 LEA3 LEA 3–12 99 9.56 10,350.8 Dt04_chr22 855,441 855,830 389 cyto mTP S
CotAD_ 24,498 LEA3 LEA 3–8 126 6.27 13,502.83 Dt03_chr17 1,079,773 1,082,222 2449 chlo mTP M
CotAD_ 26,668 LEA3 LEA 3–16 98 9.34 10,595.99 scaffold141.1 891,415 891,795 380 chlo mTP M
CotAD_ 33,003 LEA3 LEA 3–15 120 7.02 13,729.35 scaffold944.1 428,674 429,107 433 chlo mTP M
CotAD_ 35,021 LEA3 LEA 3–5 85 9.77 9781.28 At_chr11 537,390 537,732 342 chlo mTP M
CotAD_ 36,999 LEA3 LEA 3–4 126 6.27 13,484.86 At_chr08 1,181,217 1,183,629 2412 cyto mTP M
CotAD_ 40,972 LEA3 LEA 3–7 124 9.51 14,155.5 At_chr13 122,903 123,887 984 chlo mTP M
CotAD_ 41,714 LEA3 LEA 3–14 105 9.3 11,363.76 Dt11_chr21 445,383 445,797 414 chlo mTP M
CotAD_ 43,605 LEA3 LEA 3–3 92 9.75 9709.1 At_chr04 475,252 475,623 371 nucl mTP C
CotAD_ 46,270 LEA3 LEA 3–6 105 9.51 11,449.87 At_chr11 673,169 673,590 421 golg mTP S
CotAD_ 56,728 LEA3 LEA 3–10 98 9.66 10,549.99 Dt04_chr22 520,431 520,811 380 golg mTP S
CotAD_ 00667 LEA4 LEA 4–12 239 9.03 26,335.09 scaffold26.1 961,112 961,910 798 chlo cTP C
CotAD_ 02872 LEA4 LEA 4–4 569 5.89 62,916.57 Dt05_chr19 496,264 498,058 1794 mito other _
CotAD_ 05963 LEA4 LEA 4–5 266 5.2 29,264.99 Dt05_chr19 2,777,842 2,778,935 1093 extr SP S
CotAD_ 09404 LEA4 LEA 4–7 127 9.21 13,553.37 Dt07_chr16 2,927,050 2,928,024 974 chlo cTP C
CotAD_ 09405 LEA4 LEA 4–8 109 9.96 12,066.81 Dt07_chr16 2,946,007 2,947,047 1040 chlo mTP M
CotAD_ 10,044 LEA4 LEA 4–3 634 5.78 68,352.06 At_chr07 513,343 515,454 2111 nucl mTP _
CotAD_ 13,989 LEA4 LEA 4–10 109 10.04 12,094.87 Dt13_chr18 1,907,725 1,908,766 1041 chlo mTP M
CotAD_ 22,633 LEA4 LEA 4–6 136 6.93 14,614.04 Dt06_chr25 240,527 241,024 497 chlo other _
CotAD_ 23,824 LEA4 LEA 4–9 405 5.88 44,549.64 Dt12_chr26 2,459,614 2,460,913 1299 chlo other _
CotAD_ 50,359 LEA4 LEA4–1 284 5.13 31,311.17 At_chr03 809,118 810,165 1047 cyto SP S
CotAD_ 62,314 LEA4 LEA 4–11 239 9.03 26,258.97 scaffold3310.1 9965 10,763 798 cyto cTP C
CotAD_ 62,659 LEA4 LEA4–2 568 5.96 62,738.55 At_chr06 14,807 16,597 1790 cyto other _
CotAD_ 74,061 LEA4 LEA 4–4 405 5.69 44,521.59 At_chr12 408,138 409,436 1298 nucl other _
CotAD_ 03264 LEA5 LEA 5–4 110 5.55 11,915.92 Dt06_chr25 1,093,153 1,093,598 445 nucl other _
CotAD_ 07516 LEA5 LEA 5–2 123 5.78 13,999.94 At_chr09 1,687,267 1,687,988 721 cyto other _
CotAD_ 22,539 LEA5 LEA 5–9 102 5.49 11,072.09 scaffold613.1 610,955 611,364 409 chlo other _
CotAD_ 31,869 LEA5 LEA 5–8 102 5.49 11,072.09 scaffold1551.1 323,034 323,444 410 nucl other _
CotAD_ 33,321 LEA5 LEA 5–7 110 5.55 11,972.03 scaffold1788.1 214,115 214,558 443 chlo other _
CotAD_ 46,888 LEA5 LEA 5–1 144 7.76 16,526.85 At_chr08 563,572 564,774 1202 chlo other _
CotAD_ 48,469 LEA5 LEA 5–5 171 8.39 19,503.27 Dt08_chr24 159,604 160,805 1201 nucl other _
CotAD_ 56,699 LEA5 LEA 5–6 94 8.1 10,073.96 Dt10_chr20 81,020 81,398 378 chlo other _
CotAD_ 57,519 LEA5 LEA 5–3 94 8.1 10,073.96 At_chr12 153,745 154,123 378 vacu other _
CotAD_ 13,789 LEA6 LEA 6–3 86 7.8 9580.48 Dt12_chr26 651,517 651,777 260 nucl other _
CotAD_ 19,623 LEA6 LEA6–1 94 4.76 10,176.98 At_chr01 1,336,340 1,336,624 284 extr other _
CotAD_ 44,941 LEA6 LEA 6–4 114 11.83 11,963.43 scaffold3339.1 62,119 62,571 452 cyto other _
CotAD_ 53,438 LEA6 LEA 6–2 94 4.75 10,257.11 Dt07_chr16 78,654 78,938 284 chlo SP M
CotAD_ 11,594 SMP SMP-10 264 4.85 26,898.86 scaffold189.1 992,496 993,467 971 cyto other _
CotAD_ 12,680 SMP SMP-3 169 4.63 17,180.76 At_chr07 1,633,754 1,634,391 637 cyto other _
CotAD_ 12,681 SMP SMP-4 144 4.61 14,950.53 At_chr07 1,636,123 1,636,635 512 chlo other _
CotAD_ 12,682 SMP SMP-5 258 4.56 26,168.03 At_chr07 1,639,467 1,640,458 991 cyto other _
CotAD_ 39,233 SMP SMP-7 171 4.49 17,755.88 Dt13_chr18 1,963,715 1,964,463 748 chlo other _
CotAD_ 43,455 SMP SMP-6 261 4.79 26,971.01 Dt12_chr26 1,316,599 1,317,706 1107 chlo other _
CotAD_ 45,390 SMP SMP-1 252 6.35 26,222.21 At_chr01 335,790 337,578 1788 chlo other _
CotAD_ 51,205 SMP SMP-9 253 6.46 26,151.04 scaffold1984.1 277,433 279,262 1829 chlo other _
CotAD_ 66,708 SMP SMP-2 258 6.44 27,923.82 At_chr04 123,169 126,337 3168 cyto other _
CotAD_ 67,721 SMP SMP-8 264 4.93 26,885.82 scaffold4155.1 34,277 35,248 971 cyto other _
  1. LEA: late embryogenesis abundant protein; LEA1, 2, 3, 4, 5 and 6 indicates the sub families of LEA proteins while the −1, −2,-3…. Represents the protein annotation number i.e. LEA1–1, the first member of LEA1 sub family; SMP: seed maturation protein; chlo: chloroplast; cyto: cytoplasm; extr: extracellular part of the cell; nucl: nucleus; mito: mitochondrion; cysk: cytoskeleton; golg: golgi body; vacu: vacuole; plas: plasma membrane; E.R: endoplasmic reticulum; SP: Secretory pathway (presence of a signal peptide); mTP: mitochondrial targeting peptide; cTP: chloroplast transit peptide; Other (nucleus, cytoplasmic, or otherwise). C: cytoplasm; S: secretory pathway; M: mitochondrion and -: others/other cell organelles; chr: chromosome; Dt: sub genome D and At: sub-genome A